Table of Contents

SSRIs, or selective serotonin reuptake inhibitors, are often the first choice for treating depression, anxiety, and other mental health conditions. They’re widely used because they’re usually safe, effective, and easy to tolerate. Many are approved for both adults and children, which makes them a common starting point for treatment.

Two of the most popular SSRIs are Lexapro (escitalopram) and Prozac (fluoxetine). They’re both well-known and commonly prescribed, but they’re not exactly the same. Some people respond better to one than the other. Side effects, how long the medication stays in your system, and how quickly it starts working can all vary.

This guide breaks down the real-world differences between Lexapro vs. Prozac, drawing on clinical data and patient outcomes to help you better understand which might align with your needs.

What Is The Difference Between Prozac And Lexapro?

Parameters Prozac Lexapro
US Average Retail Price $700 $400
Pharma Giant Price $49.99 $150
Active Ingredient Fluoxetine Escitalopram
Drug Class Selective Serotonin Reuptake Inhibitor (SSRI) Selective Serotonin Reuptake Inhibitor (SSRI)
Approved Indications Depression, OCD, Bulimia Nervosa, panic disorder, bipolar depression, and treatment-resistant depression Depression and anxiety
Route of Administration Oral capsule Oral tablet
Side Effects Abnormal dreams, abnormal ejaculation, anorexia, anxiety, weakness or lack of energy, diarrhea, dry mouth, dyspepsia, flu syndrome, impotence, insomnia, decreased libido, nausea, nervousness, pharyngitis, rash, sinusitis, somnolence, sweating, tremor, vasodilatation, and frequent yawning Insomnia, nausea, sweating, sexual issues (like reduced libido, delayed ejaculation, and difficulty reaching orgasm), fatigue, and drowsiness
Dosage and Administration Starts with 10 mg once daily and can be increased up to 80 mg, depending on the condition being treated Starts with 10 mg once daily and can be increased up to 20 mg, depending on the condition being treated

Is Prozac Better Than Lexapro?

Lexapro and Prozac both treat depression and anxiety well, but they may help different types of people. Here’s how they compare:

Prozac vs. Lexapro for Depression

Some clinical guidelines and reviews suggest Lexapro may be slightly more effective or better tolerated than Prozac in certain situations, especially during the early phase of treatment.

One review looked at 30 high-quality clinical trials where Lexapro was directly compared with other antidepressants, including SSRIs like Prozac. During the acute phase of treatment, Lexapro helped more people see symptom improvement, and fewer people stopped taking it due to side effects.

However, when looking at long-term use, the two drugs perform similarly. A separate study followed 387 patients with major depressive disorder (MDD) for nearly three years to see which SSRIs best prevented depression from coming back. Lexapro and Prozac performed equally well, showing better relapse prevention than other SSRIs in the group.

When it comes to reducing psychological distress in adults with depression, both drugs also had comparable results. In one real-world study, Prozac showed a slightly higher improvement rate (91.87%) than Lexapro (90.38%), but the difference was minimal.

Medical Insight!

Combination therapy, Prozac and olanzapine (an antipsychotic), is approved for treatment-resistant depression. This combo has been studied in four randomized, double-blind clinical trials, all involving patients who hadn’t responded well to a previous antidepressant.

The Prozac + olanzapine combo helped reduce depression symptoms quickly, as measured by the Montgomery-Asberg Depression Rating Scale (MADRS).

In two of the four trials, this combination was significantly more effective at the end of the study than antidepressants alone. The benefits were especially strong in people who had already tried and failed at least two antidepressants during their current depressive episode.

Beyond treatment-resistant depression, this combination is also approved for treating acute depressive episodes associated with Bipolar I Disorder.

Lexapro vs. Prozac for Anxiety

There aren’t many head-to-head studies comparing Lexapro and Prozac for anxiety. That’s because they’re often used to treat different types of anxiety disorders.

Lexapro is prescribed for generalized anxiety disorder (GAD). Prozac, on the other hand, is more often used for panic disorder, which is a different form of anxiety.

Still, many doctors use Prozac for GAD in practice. Similarly, Lexapro is sometimes prescribed off-label for panic disorder. This tends to occur when patients are unable to tolerate either Prozac or Lexapro.

However, one meta-analysis showed interesting results. Researchers of that study looked at nine medications for GAD and included both Prozac and Lexapro. In that analysis, Prozac ranked highest for helping with symptoms like anxiety relief and remission. This may suggest that, in broader clinical practice, Prozac still offers real benefits for some patients with GAD.

Lexapro has also been widely studied. In one clinical trial involving children and teens, those who took Lexapro had a bigger drop in anxiety symptoms compared to those who took a placebo.

Interestingly, in an animal study, Prozac increased signs of anxiety in a dose-dependent way, which might help explain why it isn’t approved for GAD. But for panic disorder, its benefits are well-supported. In clinical trials, 20 mg of Prozac daily helped reduce panic attacks and also improved overall anxiety, mood, and daily functioning.

Prozac vs. Lexapro for OCD

Unlike Prozac, Lexapro isn’t officially approved to treat obsessive-compulsive disorder (OCD), but many doctors still prescribe it off-label. That’s because it can help reduce intrusive thoughts, compulsive behaviors, and anxiety in people with OCD.

While there aren’t many head-to-head comparisons between Lexapro and Prozac, studies on each drug separately show they can both be effective.

In one 12-week study, people taking 20 mg of Lexapro daily saw greater improvement in OCD symptoms than those on placebo. It worked just as well as 40 mg of paroxetine (Paxil), another SSRI often used for OCD. In a 24-week relapse-prevention study, only 23% of those on Lexapro relapsed, compared to 52% on placebo. Most side effects were mild or moderate.

Prozac has been studied more extensively. In one trial involving children and teens with autism spectrum disorder (ASD), it helped reduce obsessive-compulsive behaviors. Scores in the Prozac group dropped by 3.72 points, compared to 2.53 points in the placebo group.

Another study focused on adults with OCD. It showed that Prozac works best at doses between 40 and 60 mg per day. Improvements usually take a few weeks to appear, but long-term use, up to three years, continued to show benefit, with more people responding over time.

Did You Know?

Major mental health organizations back Prozac (fluoxetine) for more than just depression. The American Psychiatric Association recommends it as a first-line treatment for bulimia nervosa when paired with cognitive behavioral therapy. At the same time, the American Psychological Association supports its use for post-traumatic stress disorder (PTSD) in certain cases.

How They Work

Model of a brain surrounded by green and white capsules

Lexapro contains escitalopram, while Prozac contains fluoxetine. Both are SSRIs, or selective serotonin reuptake inhibitors. They work by:

    • Increasing serotonin levels in the brain. Serotonin is a chemical that affects mood, stress, sleep, and emotional balance. In people with depression, serotonin levels in the brain fluid are often lower than normal.
    • Slowing down serotonin reabsorption. Normally, the brain reabsorbs serotonin quickly. SSRIs like Lexapro and Prozac help keep it active longer, allowing more of it to stay available in the brain.
    • Acting on areas linked to mood and emotion. These medications target parts of the brain where serotonin has the biggest impact on how you feel and respond to stress.

Interestingly, a recent animal study suggests that Prozac might work in more than one way. Researchers found it may also affect the gut, specifically the vagus nerve, which is the pathway connecting the gut to the brain. The study showed that Prozac increased levels of Lactobacillus, a helpful type of gut bacteria.

When this same bacteria was given to other mice, they also reduced depression- and anxiety-like behaviors, just like Prozac did. But, when antibiotics (which kill gut bacteria) were given, it reduced the effectiveness of Prozac, suggesting that these gut microbes are part of how the drug works.

This suggests that Prozac may not only increase serotonin in the brain but also influence mood through changes in gut bacteria. Lactobacillus, in particular, may play a role by sending signals through the vagus nerve that affect serotonin-related brain activity.

Which Works Faster?

Lexapro works faster.

Lexapro is absorbed fairly quickly, reaching its highest level in the blood about five hours after you take it. It usually takes one to two weeks for the medication to fully settle into your system, which is when you start to feel its steady effects.

Prozac takes a bit longer to reach its peak, around six to eight hours after a dose. Because it stays in the body for a long time, it builds up more slowly. This means it may take a little longer before you notice the full benefits.

Which Lasts Longer?

Prozac lasts significantly longer in the body, even after stopping the medication.

After taking a dose, Prozac takes about 2 to 4 days for half of the drug to leave your system. Its active form, called norfluoxetine, lasts about 7 to 9 days. Because of this, fluoxetine can remain in your body for several weeks after you stop taking it.

Lexapro doesn’t last as long. Its half-life is much shorter, around 27 to 33 hours. That means it clears from the body more quickly once you stop taking it.

Prozac vs. Lexapro’s Side Effects

woman on couch experiencing nausea

Lexapro and Prozac are both generally well-tolerated. Because they act on the same brain chemicals, they may cause similar side effects, including:

    • Insomnia
    • Nausea
    • Sweating
    • Memory problems
    • Poor concentration
    • Yawning
    • Fatigue
    • Dry mouth
    • Sleepiness (somnolence)
    • Gas or bloating (flatulence)
    • Sexual issues such as reduced libido, delayed ejaculation, or difficulty reaching orgasm

Some side effects, though less common, are more serious. These include:

    • Extrapyramidal Symptoms (EPS): These are movement-related side effects like tremors, muscle stiffness, restlessness, or slow movement. While rare, both Lexapro and Prozac have been linked to these symptoms, especially in the first month of starting the medication or increasing the dose.
    • Serotonin syndrome: This is a rare but serious condition caused by too much serotonin. It can happen when SSRIs are taken alone or with other serotonin-boosting drugs. Symptoms might include agitation, twitching, fever, or confusion. Most cases involve overdose or switching between medications too quickly.
    • QT Prolongation (Heart Rhythm Risk): SSRIs can slightly affect the heart’s electrical activity. Lexapro may cause this at high doses, especially in older adults. But some studies haven’t found a clear link.
    • Skin Reactions: Both Lexapro and Prozac have been reported to cause skin issues like rashes, itching, and, rarely, serious allergic skin reactions. For example, one person developed a rash four weeks after starting Lexapro. Another developed hives and facial swelling on Prozac.
    • Birth Defects: SSRIs can cross the placenta during pregnancy. Prozac, in particular, has been associated with a slight increase in the risk of birth defects, mainly heart-related. Still, stopping SSRIs during pregnancy can pose serious risks to the mother’s mental health, so treatment choices need to be carefully personalized.
    • Hyponatremia: SSRIs may lower sodium levels in the blood. This is more common in older adults and in the first few weeks of treatment. It may cause weakness, confusion, or seizures in severe cases.
    • Cataracts: Some studies suggest Prozac may be linked to a higher risk of cataracts with long-term use, though findings are mixed. Regular eye exams may help catch any changes early.
    • Suicidal Thoughts (Especially in Young People): In adolescents and young adults (ages 18-24), there’s concern that starting SSRIs could temporarily increase suicidal thoughts. That’s why there’s a black box warning for this age group.

Prozac vs. Lexapro Weight Gain Considerations

woman pinching her love handles

Weight gain is often overlooked when prescribing antidepressants, but it can affect both physical and mental health and cause people to stop taking their meds. With over 70% of US adults either overweight or obese, and people with depression being even more likely to struggle with weight, choosing the right antidepressant is important.

A large two-year study looked at how much weight people gained after starting one of eight common antidepressants. It included over 183,000 adults treated across various US medical centers. The main finding was that Lexapro led to the most weight gain after six months.

Specifically, six-month weight changes (only among those who stuck with their meds) were:

    • Prozac: lost about 0.5 lb
    • Lexapro: gained 0.41 kg (~0.9 lb)

Lexapro also came with a 10-15% higher risk of significant weight gain, measured as 5% of baseline body weight or more.

These findings are similar to an earlier study. In the first 4 weeks, patients with depression who took Prozac 20 mg/day lost about 0.4 kg (roughly 1 lb). Over the longer term (up to 50 weeks), they gained about the same amount of weight as those on placebo, suggesting that any weight gain is likely part of recovering from depression, not a side effect of the drug itself.

Approved Indications of Lexapro and Prozac

Prozac has broader psychiatric indications, covering OCD, bulimia, panic disorder, and combination uses in bipolar and treatment-resistant depression.

Condition Prozac Lexapro
Major Depressive Disorder (MDD) Adults & kids 8+ Adults & kids 12+
Generalized Anxiety Disorder (GAD) Adults & kids 7+
Obsessive-Compulsive Disorder (OCD) Adults & kids 7+
Bulimia Nervosa
Panic Disorder (with or without agoraphobia)
Depressive episodes associated with Bipolar I Disorder (with Olanzapine) Adults & kids 10+
Treatment-Resistant Depression (with Olanzapine)

Dosage and Administration of Lexapro versus Prozac

Prozac offers a broader dosing range, with typical daily doses ranging from 10 to 80 mg per day, depending on the condition being treated. For example, lower doses are often used for depression or in pediatric cases, while higher doses may be necessary for conditions like bulimia nervosa.

In contrast, Lexapro has a narrower dosing range. Most patients are prescribed between 10 and 20 mg per day. This smaller range reflects Lexapro’s more focused use and typically simpler dose adjustments.

Cost of Lexapro vs. Prozac

A 30-day supply of brand-name Prozac at the 20 mg strength can cost around $437.70. The 40 mg dose may go over $700. Lexapro is also expensive, with 10 mg tablets often costing more than $400 for one month.

That said, brand-name Prozac has been discontinued in the US. Eli Lilly, the original manufacturer, announced it would stop producing the drug worldwide by the end of 2024.

Both Prozac and Lexapro are available in generic forms, which are usually much more affordable. To cut costs even further, many people choose to order their medications from a Canadian pharmacy network.

Pharma Giant, a trusted online Canadian pharmacy partner, offers these generics at a much lower price. You can get up to 300 capsules of 10 mg generic Prozac for just $129, or the 20 mg strength for $159. Lexapro is also offered at discounted rates.

There are more ways to save, too. Bulk orders, coupon codes, and a 10% discount for first-time customers can help reduce your total even more.

In Summary

Lexapro and Prozac are both effective antidepressants, but they serve different needs. Lexapro may work faster and is often preferred for generalized anxiety. It’s also well-tolerated in the early stages of treatment. Prozac lasts longer in the body and is approved for more conditions, including OCD, bulimia, and treatment-resistant depression.

Both have side effects and can cause weight changes, but Lexapro is more likely to lead to weight gain over time. Generic versions of both are available and much cheaper than brand names, especially if ordered through Canadian pharmacy services like Pharma Giant.

The better option depends on your condition, how you respond, and your doctor’s guidance.

Frequently Asked Questions

Using Prozac and Lexapro at the same time isn’t typically recommended, as both are SSRIs and combining them can increase the risk of serotonin syndrome. Always consult your doctor before mixing antidepressants.
Yes, switching is possible, but it should be done gradually under medical supervision to reduce the risk of side effects or withdrawal symptoms.
Lexapro affects people differently. Some feel more relaxed or drowsy, while others may experience increased energy or restlessness.
Prozac has been nicknamed the “happy pill” in media and pop culture because of its mood-lifting effects, but this isn’t a medical term.
Neither is universally stronger. Their effectiveness depends on your specific symptoms and how your body responds to treatment.
Avoid alcohol, certain supplements, and medications that interact with serotonin levels. It’s also best to steer clear of abrupt dose changes without your doctor’s guidance.
There’s no single “strongest” antidepressant, but medications like clozapine (for treatment-resistant depression) or ECT (electroconvulsive therapy) are considered among the most powerful options in severe cases.
Alternatives may include other SSRIs like Zoloft or Prozac, or different classes like SNRIs (e.g., Effexor XR) or atypical antidepressants like Wellbutrin. Your doctor can help find what suits you best.

Sources

Yin, J., Song, X., Wang, C., Lin, X., & Miao, M. (2023). Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. BMC Psychiatry, 23(1). https://doi.org/10.1186/s12888-023-05382-8

Peselow, E. D., Tobia, G., Karamians, R., Pizano, D., & IsHak, W. W. (2014). Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: Outcome after long-term follow-up. Psychiatry Research, 225(3), 680–686. https://doi.org/10.1016/j.psychres.2014.11.022

Adjei, K., Adunlin, G., & Ali, A. A. (2023). Impact of Sertraline, Fluoxetine, and Escitalopram on Psychological Distress among United States Adult Outpatients with a Major Depressive Disorder. Healthcare, 11(5), 740. https://doi.org/10.3390/healthcare11050740

Baldwin, D., Woods, R., Lawson, R., & Taylor, D. (2011). Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ, 342(mar11 1), d1199. https://doi.org/10.1136/bmj.d1199

Strawn, J. R., Moldauer, L., Hahn, R. D., Wise, A., Bertzos, K., Eisenberg, B., Greenberg, E., Liu, C., Gopalkrishnan, M., McVoy, M., & Knutson, J. A. (2023). A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder. Journal of Child and Adolescent Psychopharmacology, 33(3), 91–100. https://doi.org/10.1089/cap.2023.0004

Kryst, J., Majcher-Ma?lanka, I., & Chocyk, A. (2022). Effects of chronic fluoxetine treatment on anxiety- and depressive-like behaviors in adolescent rodents – systematic review and meta-analysis. Pharmacological Reports, 74(5), 920–946. https://doi.org/10.1007/s43440-022-00420-w

Apgar, B. (1999, April 1). Fluoxetine for treatment of panic disorder. AAFP. https://www.aafp.org/pubs/afp/issues/1999/0401/p1924.html

Bobo, W. (2009). Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues. Neuropsychiatric Disease and Treatment, 369. https://doi.org/10.2147/ndt.s5819

Pelissolo A. (2008). Efficacité et tolérance de l’escitalopram dans les troubles anxieux: revue de la littérature [Efficacy and tolerability of escitalopram in anxiety disorders: a review]. L’Encephale, 34(4), 400–408. https://doi.org/10.1016/j.encep.2008.04.004

Fineberg, N. A., Tonnoir, B., Lemming, O., & Stein, D. J. (2007). Escitalopram prevents relapse of obsessive-compulsive disorder. European Neuropsychopharmacology, 17(6–7), 430–439. https://doi.org/10.1016/j.euroneuro.2006.11.005

Reddihough, D. S., Marraffa, C., Mouti, A., O’Sullivan, M., Lee, K. J., Orsini, F., Hazell, P., Granich, J., Whitehouse, A. J. O., Wray, J., Dossetor, D., Santosh, P., Silove, N., & Kohn, M. (2019). Effect of Fluoxetine on Obsessive-Compulsive Behaviors in children and Adolescents with autism spectrum Disorders. JAMA, 322(16), 1561. https://doi.org/10.1001/jama.2019.14685

[Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature]. (2001, June 1). PubMed. https://pubmed.ncbi.nlm.nih.gov/11488259/

Martin, A., Naunton, M., Kosari, S., Peterson, G., Thomas, J., & Christenson, J. K. (2021). Treatment Guidelines for PTSD: A Systematic Review. Journal of clinical medicine, 10(18), 4175. https://doi.org/10.3390/jcm10184175

Crone, C., Fochtmann, L. J., Attia, E., Boland, R., Escobar, J., Fornari, V., Golden, N., Guarda, A., Jackson-Triche, M., Manzo, L., Mascolo, M., Pierce, K., Riddle, M., Seritan, A., Uniacke, B., Zucker, N., Yager, J., Craig, T. J., Hong, S., & Medicus, J. (2023). The American Psychiatric Association Practice Guideline for the Treatment of Patients with Eating Disorders. American Journal of Psychiatry, 180(2), 167–171. https://doi.org/10.1176/appi.ajp.23180001

Lee, Y., Cho, Y., & Kim, J. (2024). The unique role of fluoxetine in alleviating depression and anxiety by regulating gut microbiota and the expression of vagus nerve-mediated serotonin and melanocortin-4 receptors. Biomedicine & Pharmacotherapy, 182, 117748. https://doi.org/10.1016/j.biopha.2024.117748

Landy, K., Rosani, A., & Estevez, R. (2023, November 10). Escitalopram. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK557734/

Sohel, A. J., Shutter, M. C., Patel, P., & Molla, M. (2024, February 28). Fluoxetine. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK459223/

MPharm, K. A. (2021). Side effect Profiles of Selective Serotonin Reuptake Inhibitors: A Cross-Sectional Study in a Naturalistic setting. Psychiatrist.com. https://www.psychiatrist.com/pcc/side-effect-profiles-selective-serotonin-reuptake-inhibitors-cross-sectional-study-naturalistic-setting/

Tuman, T. C., Tuman, B., Polat, M., & Çak?r, U. (2017). Urticaria and Angioedema Associated with Fluoxetine. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 15(4), 418–419. https://doi.org/10.9758/cpn.2017.15.4.418

Mph, D. P. M. (2021). Escitalopram-Induced rash. Psychiatrist.com. https://www.psychiatrist.com/pcc/escitalopram-induced-rash/

Chou, P., Chu, C., Chen, Y., Hsu, M., Huang, M., Lan, T., & Lin, C. (2017). Antidepressants and risk of cataract development: A population-based, nested case-control study. Journal of Affective Disorders, 215, 237–244. https://doi.org/10.1016/j.jad.2017.03.044

Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., Kaye, A. D., Viswanath, O., Urits, I., Boyer, A. G., Cornett, E. M., & Kaye, A. M. (2021). Selective serotonin reuptake inhibitors and Adverse Effects: A Narrative review. Neurology International, 13(3), 387–401. https://doi.org/10.3390/neurolint13030038

Petimar, J., Young, J. G., Yu, H., Rifas-Shiman, S. L., Daley, M. F., Heerman, W. J., Janicke, D. M., Jones, W. S., Lewis, K. H., Lin, P. D., Prentice, C., Merriman, J. W., Toh, S., & Block, J. P. (2024). Medication-Induced weight change across common antidepressant treatments. Annals of Internal Medicine, 177(8), 993–1003. https://doi.org/10.7326/m23-2742

Michelson, D., Amsterdam, J. D., Quitkin, F. M., Reimherr, F. W., Rosenbaum, J. F., Zajecka, J., Sundell, K. L., Kim, Y., & Beasley, C. M. (1999). Changes in weight during a 1-Year trial of Fluoxetine. American Journal of Psychiatry, 156(8), 1170–1176. https://doi.org/10.1176/ajp.156.8.1170